Article

Special Considerations in Vascular Anomalies: Hematologic Management

Division of Hematology/Oncology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH 45229, USA.
Clinics in plastic surgery (Impact Factor: 1.35). 01/2011; 38(1):153-60. DOI: 10.1016/j.cps.2010.08.002
Source: PubMed

ABSTRACT Proper care of the patient with a vascular anomaly requires the expertise of multiple specialists. Because of the need for an interdisciplinary approach, several vascular anomalies centers have now been developed across the world. A hematologist/oncologist provides clinical acumen in establishing a correct diagnosis and guiding the medical management of these patients. These patients can have complicated coagulopathies and need medical therapy. This article emphasizes the hematologic complications and management of these patients.

0 Followers
 · 
69 Views
  • Source
    Journal der Deutschen Dermatologischen Gesellschaft 05/2013; 11(5). DOI:10.1111/ddg.12046_suppl · 1.82 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Patients with vascular anomalies present specific and unique challenges to providers of their postoperative care. Vascular anomalies can range from localized solitary lesions to diffuse lesions with vessel malformations and associated soft tissue, muscle, organ and bone involvement. Perioperative issues for these patients can be complicated and include coagulopathies requiring anticoagulation, the need for postoperative surgical drains and specialized wound care, and the use of compression garments to maintain the desired postoperative result. This article will address these specific concerns for patients with vascular anomalies in order to create a framework for consistent and appropriate perioperative care.
    Seminars in Pediatric Surgery 08/2014; 23(4). DOI:10.1053/j.sempedsurg.2014.07.007 · 1.94 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Vascular anomalies (VAs) comprise a large variety of individual diagnoses that in different phases of treatment require a diverse number of medical specialists to provide optimal care. Medical therapies include agents usually associated with cancer chemotherapy, such as vincristine, as well more immunomodulatory types of drugs, such as glucocorticoids and sirolimus. These immunomodulating drugs are being successfully applied in cases that are typically categorized as vascular tumors, including kaposiform hemangioendothelioma (KHE) and tufted angioma (TA), as well as some of the more invasive types of vascular malformations (i.e., microcystic lymphatic malformations and blue rubber bleb nevus syndrome (BRBNS). These therapies need to be combined with good supportive care, which often involves anticoagulation, antimicrobial prophylaxis, and comprehensive pain and symptom-relief strategies, as well as appropriate drug monitoring and management of side effects of medical treatment. The optimal care of these patients frequently involves close collaboration between surgeons, interventional and conventional radiologists, medical subspecialists, and nurses.
    Seminars in Plastic Surgery 05/2014; 28(2):79-86. DOI:10.1055/s-0034-1376264